Indonesian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
triterpenoid/kanker
Tautan disimpan ke clipboard
Halaman 1 dari 25 hasil
Anti-tumor activity of AECHL-1, novel triterpenoid isolated from Ailanthus excelsa in vitro and in vivo
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF INVENTION
This invention relates to a novel triterpenoid AECHIL-1, isolated from Ailanthus excelsa having anti tumor activity both in vitro and in vivo.
BACKGROUND OF INVENTION
The existing state of art in the treatment of cancer includes Chemotherapy that involves the administration of
Pentacyclic triterpenoid compounds as topoisomerase inhibitors or cell differentiation inducers
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
BACKGROUND OF THE INVENTION
FIELD OF THE INVENTION
This invention relates generally to pentacyclic triterpenoid compounds such as .alpha.-boswellic acid acetate, .beta.-boswellic acid acetate and their analogs which possess topoisomerase inhibitory, cell differentiation inducing and/or anti-cancer
Derivatives of triterpenoid acids and uses thereof
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF THE INVENTION
This invention relates generally to the field of medicinal chemistry. More specifically, it relates to derivatives of triterpenoid acids, preferably derivatives of glycyrrhetinic acid, that have dual pharmacophoric properties, formulations containing such and their use to
Derivatives of triterpenoid acids and uses thereof.
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF THE INVENTION
This invention relates generally to the field of medicinal chemistry. More specifically, it relates to derivatives of triterpenoid acids, preferably derivatives of glycyrrhetinic acid, that have dual pharmacophoric properties, formulations containing such and their use to
Derivatives of triterpenoid acids and uses thereof
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF THE INVENTION
This invention relates generally to the field of medicinal chemistry. More specifically, it relates to derivatives of triterpenoid acids, preferably derivatives of glycyrrhetinic acid, that have dual pharmacophoric properties, formulations containing such and their use to
Methods of treating diseases using triterpenoid acid derivatives
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF THE INVENTION
This invention relates generally to the field of medicinal chemistry. More specifically, it relates to derivatives of triterpenoid acids, preferably derivatives of glycyrrhetinic acid, that have dual pharmacophoric properties, formulations containing such and their use to
Therapeutic composition for treating cancers
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present disclosure relates to a therapeutic composition comprising a novel combination of triterpenoids for treating cancers, including drug-resistant cancers.
2. Description of Related Art
Edible fungus has long been used as a nutritional
Treatment of subjects with multidrug-resistant cancer
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
TECHNICAL FIELD
The present invention relates in a first aspect to a method for treating a subject suffering from a multidrug-resistant cancer, i.e. a cancer with multidrug-resistant phenotype and, thus, a specific subgroup of subjects with cancer. The method comprises administrating a
Use of compounds isolated from Euphorbia neriifolia for treating cancer and/or thrombocytopenia
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present disclosure relates to novel use of compounds isolated from Euphorbia neriifolia for manufacturing a medicament or a pharmaceutical composition for treating cancer and/or thrombocytopenia.
2. Description of Related Art
The leaves
Composition comprising hepatic therapeutic active for treating liver diseases, certain cancers and liver health maintenance
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF THE INVENTION
The present invention broadly relates to compositions comprising hepatic therapeutic actives comprising one or more acridone compounds, one or more xanthone compounds, one or more thioxanthone compounds, one or more tocotrienol compounds, and one or more oleanolic triterpenoid
Composition comprising hepatic therapeutic active for treating liver diseases, certain cancers and liver health maintenance
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF THE INVENTION
The present invention broadly relates to compositions comprising hepatic therapeutic actives comprising one or more acridone compounds, one or more xanthone compounds, one or more thioxanthone compounds, one or more tocotrienol compounds, and one or more oleanolic triterpenoid
Composition comprising hepatic therapeutic active for treating liver diseases, certain cancers and liver health maintenance
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF THE INVENTION
The present invention broadly relates to compositions comprising hepatic therapeutic actives comprising one or more acridone compounds, one or more xanthone compounds, one or more thioxanthone compounds, one or more tocotrienol compounds, and one or more oleanolic triterpenoid
Synthesis and use of anti-tumor drug LQC-Y
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
TECHNICAL FIELD
The present invention relates to chemistry and bioscience filed, and specifically relates to LQC-Y general structural formula and the synthesis and the use thereof. It is proved by pharmacological experiments that this kind of compounds have a notable anti-tumor effect. No toxic
Cancer cell growth inhibition by black bean (Phaseolus vulgaris L) extracts
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
RELATED APPLICATIONS/INCORPORATION BY REFERENCE
All documents cited or referenced herein ("herein cited documents"), and all documents cited or referenced in the herein cited documents, together with any manufacturer's instructions, descriptions, product specifications, and product sheets for any
Composition containing total triterpenoid sapogenins extracted from bamboo, and the preparation method and use thereof
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF THE INVENTION
This invention relates generally to a composition containing total triterpenoid sapogenins extracted from bamboo, as well as the preparation method and use thereof. These triterpenoids are extracted from bamboo using CO.sub.2 Supercritical Fluid Extraction (SFE) technique.
Database tanaman obat terlengkap yang didukung oleh sains
- Bekerja dalam 55 bahasa
- Pengobatan herbal didukung oleh sains
- Pengenalan herbal melalui gambar
- Peta GPS interaktif - beri tag herba di lokasi (segera hadir)
- Baca publikasi ilmiah yang terkait dengan pencarian Anda
- Cari tanaman obat berdasarkan efeknya
- Atur minat Anda dan ikuti perkembangan berita, uji klinis, dan paten
Ketikkan gejala atau penyakit dan baca tentang jamu yang mungkin membantu, ketik jamu dan lihat penyakit dan gejala yang digunakan untuk melawannya.
* Semua informasi didasarkan pada penelitian ilmiah yang dipublikasikan
